Evidence map›Paper›PMID 22593212›Full record

ArticleMolecular biology of the cell2012

Endoglin regulates PI3-kinase/Akt trafficking and signaling to alter endothelial capillary stability during angiogenesis.

Nam Y Lee, Christelle Golzio, Catherine E Gatza, Arun Sharma, Nicholas Katsanis, Gerard C Blobe

Abstract read
In one paragraph

Article in Molecular biology of the cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Regulation of Blood-Brain Barrier Transporters by Transforming Growth Factor-Drug metabolism and disposition: the biological fate of chemicals · 2022
    Article
  6. Article
  7. TGF-β superfamily co-receptors in cancer.Developmental dynamics : an official publication of the American Association of Anatomists · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Endoglin in the Spotlight to Treat Cancer.International journal of molecular sciences · 2021
    Review
  12. Review
  13. Review
  14. Article
  15. BMP9 directly induces rapid GSK3-β phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  16. Article
  17. Bone Morphogenetic Proteins in Vascular Homeostasis and Disease.Cold Spring Harbor perspectives in biology · 2018
    Review
  18. Article
  19. PI3K and ERK signaling pathways are involved in differentiation of monocytic cells induced by 27-hydroxycholesterol.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Nam Y LeeDepartment of Medicine, Duke University, Durham, NC 27708, USA.
Christelle Golzio
Catherine E Gatza
Arun Sharma
Nicholas Katsanis
Gerard C Blobe
Duke University · US

Funding

SOUTHWEST ONCOLOGY GROUP CA13612U10CA013612 · NCI · UNIVERSITY OF ARIZONA · PI CRANMER, LEE D · 1985 to 2013
$4.5M
Mechanism of endoglin-targeted anticancer therapyR01CA178443 · NCI · UNIVERSITY OF ARIZONA · PI LEE, NAM Y · 2014 to 2018
$1.6M
ALK-1 and Endoglin Signaling in Endothelial CellsR01CA105255 · NCI · DUKE UNIVERSITY · PI BLOBE, GERARD C · 2004 to 2008
$1.5M
Endoglin Regulates Endothelial Survival and Capillary Tube StabilityR00HL103791 · NHLBI · OHIO STATE UNIVERSITY · PI LEE, NAM Y · 2012 to 2014
$716k
Novel Roles for beta-arrestin2 in TGF-beta mediated Endoglin SignalingF32CA124139 · NCI · DUKE UNIVERSITY · PI LEE, NAM Y · 2008 to 2009
$101k
Endoglin Regulates Endothelial Survival and Capillary Tube StabilityK99HL103791 · NHLBI · DUKE UNIVERSITY · PI LEE, NAM Y · 2011 to 2011
$89k
NCI NIH HHS F32 CA124139NCI NIH HHS F32CA124139NCI NIH HHS F32CA1361252NCI NIH HHS R01 CA105255NCI NIH HHS R01CA105255NCI NIH HHS R01 CA178443NHLBI NIH HHS K99 HL103791NHLBI NIH HHS K99HL103791NHLBI NIH HHS R00 HL103791
6 · The paper itself

Abstract

Endoglin (CD105) is an endothelial-specific transforming growth factor β (TGF-β) coreceptor essential for angiogenesis and vascular homeostasis. Although endoglin dysfunction contributes to numerous vascular conditions, the mechanism of endoglin action remains poorly understood. Here we report a novel mechanism in which endoglin and Gα-interacting protein C-terminus-interacting protein (GIPC)-mediated trafficking of phosphatidylinositol 3-kinase (PI3K) regulates endothelial signaling and function. We demonstrate that endoglin interacts with the PI3K subunits p110α and p85 via GIPC to recruit and activate PI3K and Akt at the cell membrane. Opposing ligand-induced effects are observed in which TGF-β1 attenuates, whereas bone morphogenetic protein-9 enhances, endoglin/GIPC-mediated membrane scaffolding of PI3K and Akt to alter endothelial capillary tube stability in vitro. Moreover, we employ the first transgenic zebrafish model for endoglin to demonstrate that GIPC is a critical component of endoglin function during developmental angiogenesis in vivo. These studies define a novel non-Smad function for endoglin and GIPC in regulating endothelial cell function during angiogenesis.

Indexed as

Neovascularization, PhysiologicAdaptor Proteins, Signal TransducingAnimalsAntigens, CDCapillariesCarrier ProteinsCell Culture TechniquesCell MembraneCells, CulturedEndoglinEnzyme ActivationGrowth Differentiation Factor 2Growth Differentiation FactorsHumansHuman Umbilical Vein Endothelial CellsMiceAdaptor Proteins, Signal TransducingAntigens, CDCarrier ProteinsEndoglinENG protein, humanGDF2 protein, humanGipc1 protein, mouseGrowth Differentiation Factor 2Growth Differentiation FactorsNeuropeptidesPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktReceptors, Cell SurfaceTransforming Growth Factor beta1

Identifiers

PMID22593212
PMCPMC3386206
OpenAlexW2043875953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.